7.75
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
Eye drop company LENZ heads to three investor conferences in June - Stock Titan
LENZ Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Earnings call transcript: LENZ Therapeutics sees growth in Q1 2026 By Investing.com - Investing.com Nigeria
LENZ Therapeutics (LENZ) price target decreased by 20.47% to 39.10 - MSN
LENZ Therapeutics, Inc. (LENZ) reports Q4 loss, misses revenue estimates - MSN
Users - FinancialContent
Industry Analysts Just Made A Stunning Upgrade To Their Maze Therapeutics, Inc. (NASDAQ:MAZE) Revenue Forecasts - Yahoo Finance
LENZ Therapeutics Q1 2026 earnings preview - MSN
Some LENZ Therapeutics, Inc. (NASDAQ:LENZ) Analysts Just Made A Major Cut To Next Year's Estimates - simplywall.st
Things Look Grim For LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Today's Downgrade - Yahoo Finance
Earnings Update: LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Reported And Analysts Are Trimming Their Forecasts - Sahm
LENZ Stock Price, Quote & Chart | LENZ THERAPEUTICS INC (NASDAQ:LENZ) - ChartMill
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Moomoo
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
LENZ Therapeutics, Inc. (LENZ) reports Q1 loss, beats revenue estimates - MSN
Citi Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
LENZ Therapeutics Company Profile & Introduction - Moomoo
MSN Money - MSN
A Quick Look at Today's Ratings for LENZ Therapeutics(LENZ.US), With a Forecast Between $12 to $60 - Moomoo
Lenz Therapeutics price target raised to $31 from $29 at BofA - TipRanks
LENZ Therapeutics stock price target lowered to $38 by H.C. Wainwright - Investing.com Nigeria
Lenz Therapeutics price target lowered to $38 from $48 at H.C. Wainwright - TipRanks
LENZ Therapeutics Q1 earnings call highlights - MSN
Lenz outlines sales force reaching 15,000 eye care professionals by quarter end as VIZZ adoption actions roll out - MSN
Lenz Therapeutics downgraded to Neutral from Overweight at Piper Sandler - TipRanks
Piper Sandler cuts Lenz Therapeutics stock rating on slow sales - Investing.com
Piper Sandler cuts Lenz Therapeutics stock rating on slow sales By Investing.com - Investing.com Australia
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
LENZ Therapeutics Q1 Earnings Call Highlights - inkl
Lenz Therapeutics Releases 2026 First Quarter Results - VisionMonday.com
Lenz Therapeutics reports Q1 EPS ($1.32), consensus ($1.07) - TipRanks
Lenz Therapeutics Earnings Call Balances Promise and Risk - TipRanks
LENZ: Q1 delivered 25,000 prescriptions, $1.9M revenue, and strong early adoption momentum - TradingView
TradingKey - TradingKey
Earnings call transcript: LENZ Therapeutics sees growth in Q1 2026 - Investing.com UK
LENZ: Q1 2026 delivered strong prescription growth and revenue, with robust cash and expanding adoption - TradingView
LENZ Therapeutics, Inc. (LENZ) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
LENZ Therapeutics (NASDAQ:LENZ) Q1 Report Shows Revenue Beat But Deepening Losses Sink Stock - ChartMill
LENZ THERAPEUTICS ($LENZ) Releases Q1 2026 Earnings - Quiver Quantitative
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):